Micropoint's rapid point-of-care and home test products span a range of clinical applications for medical teams seeking to expedite diagnosis and evaluation where accuracy and early intervention is critical. These life-threatening diseases burden society with mounting healthcare costs in the hundreds of billions per year. Micropoint's point-of-care diagnostic tests help lower costs by quickly detecting conditions and events early -- in hospital, or at home through self-testing -- so that medical teams can determine the most effective preventive therapy and get patients back to their lifestyles.
We have strong expertise in cardiovascular disease diagnostics and assessment, including heart failure, myocardial infarctions, and embolisms. We provide a range of tests for anticoagulants used in stroke, heart attack and venous thromboembolisms, including deep vein thrombosis (DVT) and pulmonary embolisms (PE). Our tests for sepsis and severe systemic bacterials infections enable medical teams to differentiate between infection types. The company is constantly researching new application areas for pressing medical needs. Micropoint is currently readying lipids and glucose tests for the market.